Freestone Grove Partners »

Upstream Bio shares owned by Freestone Grove Partners

Quarter-by-quarter ownership of Upstream Bio (UPB) shares owned by Freestone Grove Partners from 13F filings

Historical chart of Freestone Grove Partners investment in Upstream Bio

Tip: Access up to 7 years of quarterly data

All positions including Upstream Bio held by Freestone Grove Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Upstream Bio by Freestone Grove Partners

Quarter filed Position value Share count Share price at filing
2026-03-31 $9 1 9.00

More positions owned by Freestone Grove Partners

Vanguard Index Fds S&p 500 Etf Shs (VOO)
Ishares Tr Core S&p500 Etf (IVV)
State Str Spdr S&p 500 Etf T Tr Unit Put Option (SPY)
Johnson & Johnson (JNJ)
Citigroup Com New (C)
Axis Cap Hldgs SHS (AXS)
Datadog Cl A Com (DDOG)
Booz Allen Hamilton Hldg Cor Cl A (BAH)
BP Sponsored Adr (BP)
Elastic N V Ord Shs (ESTC)
Pinnacle Finl Partners (PNFP)
Intuitive Surgical Com New (ISRG)
Dynatrace Com New (DT)
Xcel Energy (XEL)
Mondelez Intl Cl A (MDLZ)

View all positions for Freestone Grove Partners

Top funds holding Upstream Bio

FMR
OrbiMed Advisors
BlackRock
Decheng Capital
Enavate Sciences GP
Vanguard Group
Vanguard Capital Management
Omega Fund Management
State Street Corporation
Y-Intercept
Federated Investors
Geode Capital Management
Millennium Management
Wellington Management Company
SEB Asset Management AB

View all funds holding Upstream Bio